# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA5252437 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
2. | ALA5252438 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 43300 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
3. | ALA5252439 | F | Antibacterial activity against Methicillin-resistant Staphylococcus epidermidis ATCC 51625 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus epidermidis | 34 | organism-based format | Scientific Literature | ||
4. | ALA5252440 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 29213 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
5. | ALA5252441 | F | Antibacterial activity against Methicillin-sensitive Staphylococcus epidermidis ATCC 12228 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus epidermidis | 34 | organism-based format | Scientific Literature | ||
6. | ALA5252442 | F | Antibacterial activity against Staphylococcus aureus ATCC 25923 assessed as bacterial growth inhibition incubated for 20 to 24 hrs by microbroth serial dilution assay | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
7. | ALA5252452 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in IP dosed ICR mouse assessed as reduction in inflammation by hematoxylin and eosin staining based light microscopic analysis | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
8. | ALA5252453 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in ICR mouse assessed as number of inflammatory cells at 20 mg/kg, IP by hematoxylin and eosin staining based light microscopic analysis | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
9. | ALA5252454 | F | Antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in ICR mouse assessed as number of inflammatory cells at 40 mg/kg, IP by hematoxylin and eosin staining based light microscopic analysis | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
10. | ALA5252457 | F | Invivo antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in mouse skin infection model assessed as wound healing treated as ointment at 2 % administered every 24 hrs and measured after 5 days | Staphylococcus aureus | 1 | organism-based format | Scientific Literature | ||
11. | ALA5252459 | F | Invivo antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in mouse skin infection model assessed as decrease in TNF-alpha level treated as ointment at 2 % administered every 24 hrs and measured after 5 days by ELISA assay | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
12. | ALA5252462 | F | Invivo antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in mouse skin infection model assessed as decrease in IL-6 level treated as ointment at 2 % administered every 24 hrs and measured after 5 days by ELISA assay | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
13. | ALA5252465 | F | Invivo antibacterial activity against Methicillin-resistant Staphylococcus aureus infected in mouse skin infection model assessed as decrease in MCP-1 level treated as ointment at 2 % administered every 24 hrs and measured after 5 days by ELISA assay | Staphylococcus aureus | 2 | organism-based format | Scientific Literature | ||
14. | ALA5252467 | F | Selectivity ratio of MBC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 to MIC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 33591 | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
15. | ALA5252468 | F | Selectivity ratio of MBC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 43300 to MIC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 43300 | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
16. | ALA5252469 | F | Selectivity ratio of MBC for antibacterial activity against Methicillin-resistant Staphylococcus epidermidis ATCC 51625 to MIC for antibacterial activity against Methicillin-resistant Staphylococcus epidermidis ATCC 51625 | Staphylococcus epidermidis | 34 | organism-based format | Scientific Literature | ||
17. | ALA5252470 | F | Selectivity ratio of MBC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 29213 to MIC for antibacterial activity against Methicillin-resistant Staphylococcus aureus ATCC 29213 | Staphylococcus aureus | 34 | organism-based format | Scientific Literature | ||
18. | ALA5252471 | F | Selectivity ratio of MBC for antibacterial activity against Methicillin-sensitive Staphylococcus epidermidis ATCC 1228 to MIC for antibacterial activity against Methicillin-sensitive Staphylococcus epidermidis ATCC 1228 | Staphylococcus epidermidis | 34 | organism-based format | Scientific Literature | ||
19. | ALA5252472 | F | Selectivity ratio of MBC for antibacterial activity against Staphylococcus aureus to MIC for antibacterial activity against Staphylococcus aureus | Staphylococcus aureus | 33 | organism-based format | Scientific Literature |